SCHEMBL6977199

SCHEMBL6977199

O=c1c(Cc2cccnc2)cn2c3cc(Br)ccc3c3cc(OCc4cccnc4)cc1c32

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.39
GABRA5 P31644 1/20 0.39
PKM P14618 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 1/20 0.36
HIF1A Q16665 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PRKDC P78527 4/20 0.36
GRM2 Q14416 1/20 0.35
PARP15 Q460N3 1/20 0.34
PARP10 Q53GL7 1/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
MAOA P21397 1/20 0.34
DYRK1A Q13627 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673131 0.96 GABRA1 (0.39) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6981594 0.95 GABRA1 (0.37) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6979179 0.93 GABRA1 (0.39) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL7976574 0.92 GABRA1 (0.35) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL7673377 0.91 GABRA1 (0.39) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL7666407 0.91 GABRA1 (0.35) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL7666416 0.91 GABRA1 (0.35) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6974311 0.90 GABRA1 (0.37) GABRA1GABRA5PKMALDH1A1MEN1
SCHEMBL6980050 0.90 GABRA1 (0.39) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6978286 0.90 FPR1 (0.34) GABRA1GABRA5PKMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed